Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Management of Persistent Ear Infection After Augmentin

Immediate Assessment and Next Steps

  • The American Academy of Pediatrics recommends reassessing the patient within 48-72 hours to confirm true treatment failure, defined as worsening symptoms, persistence beyond 48 hours, or recurrence within 4 days of completing therapy 1, 2
  • Verify adherence to therapy, as patients often over-administer when pain is severe and under-administer as symptoms improve, leading to apparent treatment failure 3
  • Confirm the diagnosis by re-examining the tympanic membrane to ensure middle ear effusion is still present with signs of inflammation 2, 4
  • Assess for complications, such as infection extending beyond the ear canal or host factors requiring systemic therapy 3

Antibiotic Escalation Strategy

  • For persistent severe symptoms with unimproved otologic findings, administer intramuscular ceftriaxone 50 mg/kg for 3 consecutive days, which is superior to single-dose regimens for treatment-resistant cases 1
  • This 3-day course of ceftriaxone covers resistant Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis, the predominant pathogens in treatment failure 1

When to Perform Tympanocentesis

  • Consider tympanocentesis with culture when multiple antibiotic courses have failed, or the patient has severe refractory symptoms requiring bacteriologic diagnosis and susceptibility testing 1
  • Tympanocentesis is also indicated when unusual pathogens are suspected after topical antibacterial therapy has altered canal flora 3

Alternative Considerations for Multiple Treatment Failures

  • If ceftriaxone fails or is unavailable, consider clindamycin with or without coverage for H. influenzae and M. catarrhalis (cefdinir, cefixime, or cefuroxime) 1
  • However, caution is advised as S. pneumoniae serotype 19A is usually multidrug-resistant and may not respond to clindamycin 1

Critical Pitfalls to Avoid

  • Do not use trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole, as pneumococcal resistance to these agents is substantial, making them inappropriate for Augmentin failures 1, 4
  • Do not prescribe antibiotics without visualizing the tympanic membrane, as adequate visualization is essential to confirm persistent infection versus middle ear effusion without acute infection 2

When to Refer to ENT

  • Refer for specialist evaluation if the patient fails to respond after multiple antibiotic courses and tympanocentesis is needed, or if severe refractory symptoms suggest malignant otitis externa or carcinoma 1, 3
  • Referral is also indicated if structural abnormalities, foreign body, or unrecognized perforated tympanic membrane are suspected, or if the patient is under 2 years with difficult tympanic membrane visualization requiring cerumen removal 2, 3

REFERENCES

3

clinical practice guideline: acute otitis externa. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

4

Acute Otitis Media Diagnosis and Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025